Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
3101
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $618K | ﹤0.01% |
+82,717
| New | +$638K |
|
|
IEA
3102
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $617K | ﹤0.01% |
+47,947
| New | +$601K |
|
3103
Alibaba
BABA
$279B
| $609K | ﹤0.01% |
2,686
-98,347
| -97% | -$21.9M |
|
|
KG
3104
Kestrel Group
KG
$67.1M
| $609K | ﹤0.01% |
9,026
+8,081
| +855% | +$562K |
|
3105
XBiotech
XBIT
$68.3M
| $609K | ﹤0.01% |
36,752
| – | – |
|
3106
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.5B
| $606K | ﹤0.01% |
18,707
-2,325
| -11% | -$75.1K |
|
3107
Graham Corp
GHM
$1.1B
| $604K | ﹤0.01% |
43,859
-23,143
| -35% | -$329K |
|
|
TCDA
3108
DELISTED
Tricida, Inc. Common Stock
TCDA
| $604K | ﹤0.01% |
139,794
-48,468
| -26% | -$231K |
|
3109
Mustang Bio
MBIO
$4.5M
| $594K | ﹤0.01% |
238
+81
| +52% | +$199K |
|
3110
Centrus Energy
LEU
$3.48B
| $591K | ﹤0.01% |
+23,247
| New | +$555K |
|
3111
iShares S&P GSCI Commodity-Indexed Trust
GSG
$995M
| $589K | ﹤0.01% |
36,579
-69
| -0.2% | -$1.05K |
|
|
XOMA
3112
DELISTED
Xoma
XOMA
| $588K | ﹤0.01% |
17,290
| – | – |
|
|
MCBC
3113
DELISTED
Macatawa Bank Corp
MCBC
| $586K | ﹤0.01% |
66,891
+411
| +0.6% | +$3.92K |
|
3114
Escalade
ESCA
$288M
| $585K | ﹤0.01% |
25,489
+83
| +0.3% | +$1.9K |
|
3115
Quad
QUAD
$509M
| $584K | ﹤0.01% |
140,649
-91,631
| -39% | -$332K |
|
|
FORA
3116
DELISTED
Forian
FORA
| $579K | ﹤0.01% |
+46,033
| New | +$526K |
|
3117
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
| $576K | ﹤0.01% |
6,585
-2,119
| -24% | -$183K |
|
3118
Nature's Sunshine
NATR
$357M
| $573K | ﹤0.01% |
32,953
+7,846
| +31% | +$155K |
|
3119
Mastech Digital
MHH
$95.4M
| $572K | ﹤0.01% |
38,217
-8,387
| -18% | -$135K |
|
3120
Bassett Furniture
BSET
$168M
| $571K | ﹤0.01% |
+23,440
| New | +$686K |
|
3121
Pulse Biosciences
PLSE
$2.43B
| $571K | ﹤0.01% |
34,812
-814
| -2% | -$15.5K |
|
3122
Thryv Holdings
THRY
$180M
| $571K | ﹤0.01% |
+15,954
| New | +$451K |
|
|
NMTR
3123
DELISTED
9 Meters Biopharma
NMTR
| $571K | ﹤0.01% |
25,931
+22,529
| +662% | +$553K |
|
3124
Cardiff Oncology
CRDF
$66.2M
| $570K | ﹤0.01% |
+85,617
| New | +$726K |
|
3125
Fulcrum Therapeutics
FULC
$248M
| $569K | ﹤0.01% |
54,284
+10,654
| +24% | +$108K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.